Sheldon Koenig, Esperion CEO

Seek­ing 'fi­nan­cial flex­i­bil­i­ty,' Es­pe­ri­on sells Eu­ro­pean roy­al­ty on cho­les­terol-low­er­ing drugs

Es­pe­ri­on has made an­oth­er deal with a fi­nan­cial backer for an im­me­di­ate cash haul in re­turn for fu­ture rev­enue.

Es­pe­ri­on re­ceived $304.7 mil­lion from the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.